A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine

Migraine is a commonly occurring, chronic disorder that can cause significant disability. Eletriptan, a selective serotonin 5-hydroxytryptamine 1 receptor subtype B/D (5-HT(1B/1D)) agonist, is a clinically effective treatment for moderate to severe migraine. The objective of this literature review w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhambri, Rahul, Mardekian, Jack, Liu, Larry Z, Schweizer, Edward, Ramos, Elodie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296958/
https://www.ncbi.nlm.nih.gov/pubmed/25624770
http://dx.doi.org/10.2147/IJGM.S73673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296958/
https://www.ncbi.nlm.nih.gov/pubmed/25624770
http://dx.doi.org/10.2147/IJGM.S73673

Ejemplares similares